Earnings Feed
Start Free
Home/Filings/4/0001144204-17-032755
4//SEC Filing

ENZO BIOCHEM INC 4

Accession 0001144204-17-032755

CIK 0000316253operating
View on SEC.govCompany Profile

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 5:10 PM ET

Size

10.2 KB

Accession

0001144204-17-032755

Insider Transaction Report

Form 4
Period: 2017-06-13
ENZO BIOCHEM INCENZ
O'Brien James Michael
SVP of Finance
Transactions
  • Sale

    Common Stock

    2017-06-13$10.13/sh−13,300$134,729→ 13,300 total
  • Exercise/Conversion

    Stock Option (to acquire common stock)

    2017-06-13$3.40/sh−2,500$8,500→ 75,200 total
    Exercise: $3.40From: 2016-01-22Exp: 2020-01-20→ Common Stock (2,500 underlying)
  • Sale

    Common Stock

    2017-06-13$10.13/sh−2,500$25,325→ 15,800 total
  • Exercise/Conversion

    Stock Option (to acquire common stock)

    2017-06-13$2.75/sh−13,300$36,575→ 77,700 total
    Exercise: $2.75From: 2017-02-02Exp: 2019-02-02→ Common Stock (13,300 underlying)

Documents

1 file

Issuer

ENZO BIOCHEM INC

CIK 0000316253

→
Entity typeoperating
IncorporatedNY

Related Parties

1
  • filerCIK 0000316253

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:10 PM ET
Size
10.2 KB
View on SEC.gov